| pubmed-article:12488289 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12488289 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12488289 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:12488289 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12488289 | lifeskim:mentions | umls-concept:C0210630 | lld:lifeskim |
| pubmed-article:12488289 | lifeskim:mentions | umls-concept:C1136535 | lld:lifeskim |
| pubmed-article:12488289 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:12488289 | lifeskim:mentions | umls-concept:C0332173 | lld:lifeskim |
| pubmed-article:12488289 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12488289 | pubmed:dateCreated | 2002-12-18 | lld:pubmed |
| pubmed-article:12488289 | pubmed:abstractText | We evaluated the efficacy of a single fixed 6 mg dose of pegfilgrastim (a pegylated version of filgrastim) per cycle of chemotherapy, compared with daily administration of filgrastim, in the provision of neutrophil support. | lld:pubmed |
| pubmed-article:12488289 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12488289 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12488289 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12488289 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:12488289 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:GreenM DMD | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:GasconPP | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:ClemensM RMR | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:SienaSS | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:KoelblHH | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:PiccartM JMJ | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:SamoniggHH | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:LiangB CBC | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:BaselgaJJ | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:GuillemVV | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:RenwickJJ | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:LalisangR IRI | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:ZaniVV | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:GalidAA | lld:pubmed |
| pubmed-article:12488289 | pubmed:author | pubmed-author:International... | lld:pubmed |
| pubmed-article:12488289 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12488289 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:12488289 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12488289 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12488289 | pubmed:pagination | 29-35 | lld:pubmed |
| pubmed-article:12488289 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:meshHeading | pubmed-meshheading:12488289... | lld:pubmed |
| pubmed-article:12488289 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12488289 | pubmed:articleTitle | A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. | lld:pubmed |
| pubmed-article:12488289 | pubmed:affiliation | Royal Melbourne Hospital, Melbourne, Australia. michael.green@mh.org.au | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Comment | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:12488289 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12488289 | lld:pubmed |
